Wall Street, trade agreements with Indonesia
Digest more
U.S. stocks advanced and the dollar firmed on Friday as investors girded themselves for the week ahead, which includes a Federal Reserve policy meeting, crucial corporate results and U.S. President Donald Trump's August 1 deadline for negotiating trade deals.
Edwards Lifesciences rose 5.5 percent after likewise topping Wall Street's expectations for profit in the latest quarter. It said it saw strength across all its product groups, and it expects profit for the full year to come in at the high end of the forecasted range it had given earlier.
U.S. stocks are rising toward more records. The S&P 500 climbed 0.5% Friday and was on track to close at an all-time high every day of this week. The Dow Jones Industrial Average rose 221 points, and the Nasdaq composite added 0.
U.S. stocks followed their global counterparts higher on Wednesday, and Treasury yields reversed their three-day slide after a trade deal between the United States and Japan, and a report of a similar deal with the European Union provided welcome signs of progress in President Donald Trump's multi-front tariff negotiations.
Wall Street’s relentless rally this summer has driven stock valuations close to record levels, prompting warnings that “euphoric” markets are entering bubble territory.
President Donald Trump’s vows to roll out punishing new tariffs on Aug. 1 have barely made a ripple with investors who are convinced he’ll once again back down. But at the White House, officials insist they’re serious this time.
Wall Street hovers near records in premarket trading as attention turns to next week’s busy schedule
Wall Street was on track to open with gains on Friday, adding to record highs ahead of next week’s busy slate of earnings, job market reports, a Fed meeting and the tariff deadline. Futures for the S&P 500 and the Dow Jones Industrial Average both were up 0.
Wall Street and the dollar firmed on Friday as investors girded themselves for the week ahead, which includes a Federal Reserve policy meeting, crucial corporate results and U.S. President Donald Trump's August 1 deadline for negotiating trade deals.
Edwards Lifesciences rose 5.5% after likewise topping Wall Street’s expectations for profit in the latest quarter. It said it saw strength across all its product groups, and it expects profit for the full year to come in at the high end of the forecasted range it had given earlier.